Shanghai, China

Zifeng Wang

This inventor holds 1 USPTO granted patent. Top assignee: Shanghaitech University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zifeng Wang. Retrieved from https://idiyas.com/inventor/zifeng-wang-mi2vzstm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zifeng Wang: Innovator in Cancer Treatment

Introduction

Zifeng Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the inhibition of specific proteins that play a role in cancer progression.

Latest Patents

Zifeng Wang holds a patent titled "Compositions and methods for treating cancer by inhibiting PIWIL4." This patent provides methods for diagnosing and treating cancer by reducing the biological activity and/or expression of P-element induced wimpy testis-like protein 4 (PIWIL4). The related compositions and methods are aimed at improving cancer treatment outcomes.

Career Highlights

Zifeng Wang is affiliated with ShanghaiTech University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer therapies and patient care.

Collaborations

Zifeng Wang has worked alongside notable colleagues, including Haifan Lin and Sanhong Liu. Their combined expertise contributes to advancing research in cancer treatment.

Conclusion

Zifeng Wang is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medical research. His contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…